Archives of Biochemistry and Biophysics, Год журнала: 2024, Номер unknown, С. 110258 - 110258
Опубликована: Дек. 1, 2024
Язык: Английский
Archives of Biochemistry and Biophysics, Год журнала: 2024, Номер unknown, С. 110258 - 110258
Опубликована: Дек. 1, 2024
Язык: Английский
Computer Methods and Programs in Biomedicine, Год журнала: 2025, Номер 264, С. 108687 - 108687
Опубликована: Фев. 27, 2025
Язык: Английский
Процитировано
0Pathology - Research and Practice, Год журнала: 2025, Номер unknown, С. 155954 - 155954
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Pharmaceuticals, Год журнала: 2024, Номер 17(12), С. 1682 - 1682
Опубликована: Дек. 13, 2024
The p53 protein has attracted huge research interest over several decades due to its role as one of the most important tumor suppressors in mammals, which orchestrates a synchronous response from normal cells body various forms stress. diverse cellular activities are regulated mainly via post-translational modifications (PTMs). PTMs affect on levels: at level assembly tetrameric complexes DNA transactivate target genes, genes; proteolysis absence stress; and contrary, augmented stability stress signals. Disruptions these regulatory mechanisms can lead deviations function, boosting initiation progression. Conversely, targeted interventions pathways could prove beneficial for development antitumor therapies. Advancing our understanding modifiers proteins involved regulation equips researchers with an expanded toolkit studying processes developing biologically active molecules that influence p53-mediated responses.
Язык: Английский
Процитировано
1Archives of Biochemistry and Biophysics, Год журнала: 2024, Номер unknown, С. 110258 - 110258
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
0